89 results
6-K
EX-99.2
BLU
Bellus Health Inc
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
Officers based on the following criteria:
the then current market value of the underlying Common Shares;
the “Black-Scholes” value of the stock options … .
Calculated as of the grant date using the Black-Scholes option pricing model. In 2021, the value shown is calculated by multiplying the number of option
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
based on the following criteria:
the then current market value of the underlying Common Shares;
the “Black-Scholes” value of the stock options … , converted into US dollars at the average rate of the corresponding year.
Calculated as of the grant date using the Black-Scholes option pricing model
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
Executive Officers based on the following criteria:
the then current market value of the underlying Common Shares;
the “Black-Scholes” value … , converted into US dollars at the average rate of the corresponding year.
Calculated as of the grant date using the Black-Scholes option pricing model
6-K
EX-99.2
BLU
Bellus Health Inc
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
to the Named Executive Officers based on the following criteria:
the then current market value of the underlying Common Shares;
the “Black-Scholes” value … the Black-Scholes option pricing model. The value shown is calculated by multiplying the number of option awards granted by their Black-Scholes weighted
6-K
EX-99.2
BLU
Bellus Health Inc
8 Apr 20
Notice of Annual and Special Meeting of Shareholders
9:41am
of the underlying Common Shares;
the “Black-Scholes” value of the stock options (as referred to herein);
the number of previously-granted stock options … of the option awards, the Black-Scholes model, an established methodology, was used, with the following weighted average assumptions:
Risk-free interest
F-10
EX-4.4
xvzagi3j
3 Sep 19
Registration of securities (Canada)
7:53am
F-10
EX-4.4
slevs4qs uj4
20 Dec 19
Registration of securities (Canada)
4:03pm
6-K
EX-99.2
taelu562 fe
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
hd8q0
16 Aug 07
Current report (foreign)
12:00am
6-K
4nguxs
19 Nov 07
Current report (foreign)
12:00am
6-K
EX-99.1
p4g273nx
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
6-K
EX-99.1
hj9vl 5y2xzng0qebipy
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.1
w1zyea e69vv
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
oj3akoutazi9
10 Aug 07
Current report (foreign)
12:00am
F-10
EX-4.5
ny9xcp
3 Sep 19
Registration of securities (Canada)
7:53am
6-K
EX-99.1
y7sjqx6udrx ujlyg0rz
14 May 20
Condensed Consolidated Interim Financial Statements of
5:12pm
6-K
EX-99.1
9mb7gy qtvka
10 May 21
Condensed Consolidated Interim Financial Statements of
4:48pm
6-K
EX-99.1
a9w1vlmnv0cee8y
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
40-F/A
EX-99.4
zai9xjmw bfx96
13 Mar 07
Annual report (Canada) (amended)
12:00am
40-F
EX-99.4
to1oeqsljun 2c4uyk3r
2 Mar 07
Annual report (Canada)
12:00am